Hydrocodone/paracetamol controlled-release - Mallinckrodt

Drug Profile

Hydrocodone/paracetamol controlled-release - Mallinckrodt

Alternative Names: Acetaminophen/hydrocodone controlled release - Mallinckrodt; COV-155; Hydrocodone bitartrate/acetaminophen extended release - Mallinckrodt; Hydrocodone/acetaminophen controlled release - Mallinckrodt; Hydrocodone/paracetamol controlled release - Mallinckrodt; Hydrocodone/paracetamol CR - Mallinckrodt; MNK-155; Paracetamol/hydrocodone - Mallinckrodt

Latest Information Update: 20 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mallinckrodt Inc.
  • Class Acetanilides; Morphine derivatives; Non-opioid analgesics; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Acute pain
  • No development reported Back pain; Musculoskeletal pain

Most Recent Events

  • 15 Aug 2018 Depomed is now called Assertio Therapeutics
  • 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Acute pain(In children) in USA (PO, Controlled release)
  • 23 Mar 2016 Mallinckrodt terminates a phase III trial for Post operative pain in USA (NCT02381132)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top